Oscar Rodriguez-Faba

6PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersScience, technology and engineering curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
The Prognostic Value of Clinical and Pathological Response to Neoadjuvant Therapy in Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Systematic Review and Clinical Implications.

|Dec 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre dataset.

Christina J Meisl, Pierre I Karakiewicz, Roland Einarsson

|Sep 28, 2021
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy.

Elisabet Cantó, Óscar Rodríguez Faba, Carlos Zamora

|Aug 10, 2021
Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guérin immunotherapy.

José Daniel Subiela, Óscar Rodríguez Faba, Júlia Aumatell

|Aug 04, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study.

Paulo Gontero, Emanuele Montanari, Morgan Roupret

|Nov 16, 2018
Performance Improvement (Pi) score: an algorithm to score Pi objectively during E-BLUS hands-on training sessions. A European Association of Urology, Section of Uro-Technology (ESUT) project.

Domenico Veneziano, Antonio Canova, Michiel Arnolds

Pageof 1

Frequent Collaborators

1 joint publications

Jacqueline Stockley

1 joint publications

Domenico Veneziano

1 joint publications

Chandra S Biyani

1 joint publications

Giovannalberto Pini